Sapna Mehtani, Ph.D., J.D.

Sapna Mehtani is Vice President, Intellectual Property and Legal Affairs at Sonata Therapeutics. Sapna is an accomplished intellectual property and transactional counsel who brings more than 20 years experience in developing and implementing IP strategies across a broad range of technology areas. At Sonata, Sapna leads the development and implementation of the company’s intellectual property strategy and manages general legal matters.

Previously, Sapna served as Lead Counsel IP, Cell and Gene Therapy at Takeda Pharmaceuticals. Prior to this role, she was Associate General Counsel and Head of Intellectual Property & Alliance Management at Brammer Bio. Before Brammer Bio, Sapna held roles at Editas Medicine as their Head of Patent Prosecution and at MilliporeSigma as a Senior Corporate Patent Counsel.

Sapna holds a J.D. from Suffolk University Law School, a Ph.D. in Cellular and Molecular Biochemistry from Loyola University of Chicago, and received her M.S. and B.S. from Jawaharlal Nehru University in Delhi and the University of Delhi, respectively.